Peroxisomal beta-oxidation disorder

Peroxisomal beta-oxidation disorder is a group of rare inherited metabolic diseases that affect how the body breaks down certain types of fats. Normally, tiny structures inside cells called peroxisomes act like recycling centers, breaking down very long-chain fatty acids and other substances. When the enzymes or proteins needed for this process are missing or not working properly, these fatty acids build up to harmful levels in the blood and tissues — especially in the brain, liver, and nervous system. This group includes several related conditions, such as X-linked adrenoleukodystrophy (X-ALD), acyl-CoA oxidase deficiency, D-bifunctional protein deficiency, and multifunctional protein 2 deficiency, among others. Each condition is caused by a fault in a different gene involved in the peroxisomal fat-breakdown process. Symptoms vary widely depending on which specific disorder is involved, but commonly include problems with brain and nerve function, muscle weakness, vision and hearing loss, liver disease, and in some forms, problems with the adrenal glands. Treatment depends on the specific disorder. Some forms can be managed with dietary changes, special medical formulas, or supplements. Stem cell transplantation has helped some patients with certain forms when caught early. Research into gene therapy and other targeted treatments is ongoing, offering hope for the future. Early diagnosis is critical because some treatments work best before serious damage occurs.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly

Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest

Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)

Source: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months

Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC

Bring these to your next appointment

• Q1.Which specific peroxisomal beta-oxidation disorder does my child or I have, and how does that affect the treatment options?,Should we have genetic testing for other family members, and what does this diagnosis mean for siblings or future pregnancies?,Is my child or am I a candidate for stem cell transplantation or gene therapy, and what is the window of time to consider this?,What signs of disease progression should I watch for at home, and when should I go to the emergency room?,Are there any clinical trials or research studies we should consider joining?,What dietary changes or supplements are recommended, and should we see a metabolic dietitian?,What support services — such as physical therapy, educational support, or psychological counseling — should we be accessing?

Common questions about Peroxisomal beta-oxidation disorder